The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 01, 2015
Filed:
Sep. 17, 2014
Applicant:
Oncothyreon Inc., Seattle, WA (US);
Inventor:
B. Michael Longenecker, Edmonton, CA;
Assignee:
ONCOTHYREON INC., Seattle, WA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/127 (2006.01); A61K 31/675 (2006.01); A61K 31/739 (2006.01); A61K 38/17 (2006.01); A61K 38/20 (2006.01); A61K 39/00 (2006.01); C12Q 1/68 (2006.01); A61K 47/26 (2006.01);
U.S. Cl.
CPC ...
A61K 9/127 (2013.01); A61K 31/675 (2013.01); A61K 31/739 (2013.01); A61K 38/1735 (2013.01); A61K 38/2013 (2013.01); A61K 39/0011 (2013.01); A61K 39/0012 (2013.01); A61K 47/26 (2013.01); C12Q 1/6886 (2013.01); A61K 2039/55533 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/55572 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/112 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/156 (2013.01); C12Q 2600/172 (2013.01);
Abstract
The present invention provides a method for treating an individual who is afflicted with a cancer, such as non-small cell lung cancer or prostate cancer, by administering to that individual a MUC-1-based formulation. The formulation may be a MUC-1 based liposomal vaccine formulation.